Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study "Bo-CRISP"


Phase N/A Results N/A

Trial Description

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.


Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

Patients with an acute ischemic stroke admitted to our stroke unit and treated with clopidogrel


Type Measure Time Frame Safety Issue
Primary Result of platelet function test one day No